Improving the trans-ancestry portability of polygenic risk scores by prioritizing variants in predicted cell-type-specific regulatory elements.


Journal

Nature genetics
ISSN: 1546-1718
Titre abrégé: Nat Genet
Pays: United States
ID NLM: 9216904

Informations de publication

Date de publication:
12 2020
Historique:
received: 21 02 2020
accepted: 19 10 2020
pubmed: 2 12 2020
medline: 26 1 2021
entrez: 1 12 2020
Statut: ppublish

Résumé

Poor trans-ancestry portability of polygenic risk scores is a consequence of Eurocentric genetic studies and limited knowledge of shared causal variants. Leveraging regulatory annotations may improve portability by prioritizing functional over tagging variants. We constructed a resource of 707 cell-type-specific IMPACT regulatory annotations by aggregating 5,345 epigenetic datasets to predict binding patterns of 142 transcription factors across 245 cell types. We then partitioned the common SNP heritability of 111 genome-wide association study summary statistics of European (average n ≈ 189,000) and East Asian (average n ≈ 157,000) origin. IMPACT annotations captured consistent SNP heritability between populations, suggesting prioritization of shared functional variants. Variant prioritization using IMPACT resulted in increased trans-ancestry portability of polygenic risk scores from Europeans to East Asians across all 21 phenotypes analyzed (49.9% mean relative increase in R

Identifiants

pubmed: 33257898
doi: 10.1038/s41588-020-00740-8
pii: 10.1038/s41588-020-00740-8
pmc: PMC8049522
mid: NIHMS1689007
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1346-1354

Subventions

Organisme : NHGRI NIH HHS
ID : T32 HG002295
Pays : United States
Organisme : NIAMS NIH HHS
ID : R01 AR063759
Pays : United States
Organisme : NHGRI NIH HHS
ID : U01 HG009088
Pays : United States
Organisme : Medical Research Council
ID : MR/R013926/1
Pays : United Kingdom
Organisme : NHGRI NIH HHS
ID : U01 HG009379
Pays : United States
Organisme : NIAMS NIH HHS
ID : UH2 AR067677
Pays : United States

Références

Sirugo, G., Williams, S. M. & Tishkoff, S. A. The missing diversity in human genetic studies. Cell 177, 26–31 (2019).
pubmed: 30901543 pmcid: 7380073 doi: 10.1016/j.cell.2019.02.048
Vilhjálmsson, B. J. et al. Modeling linkage disequilibrium increases accuracy of polygenic risk scores. Am. J. Hum. Genet. 97, 576–592 (2015).
pubmed: 26430803 pmcid: 4596916 doi: 10.1016/j.ajhg.2015.09.001
Finucane, H. K. et al. Partitioning heritability by functional annotation using genome-wide association summary statistics. Nat. Genet. 47, 1228–1235 (2015).
pubmed: 26414678 pmcid: 4626285 doi: 10.1038/ng.3404
Bulik-Sullivan, B. K. et al. LD Score regression distinguishes confounding from polygenicity in genome-wide association studies. Nat. Genet. 47, 291–295 (2015).
pubmed: 25642630 pmcid: 4495769 doi: 10.1038/ng.3211
Kichaev, G. & Pasaniuc, B. Leveraging functional-annotation data in trans-ethnic fine-mapping studies. Am. J. Hum. Genet. 97, 260–271 (2015).
pubmed: 26189819 pmcid: 4573268 doi: 10.1016/j.ajhg.2015.06.007
Martin, A. R. et al. Clinical use of current polygenic risk scores may exacerbate health disparities. Nat. Genet. 51, 584–591 (2019).
pubmed: 30926966 pmcid: 6563838 doi: 10.1038/s41588-019-0379-x
Lam, M. et al. Comparative genetic architectures of schizophrenia in East Asian and European populations. Nat. Genet. 51, 1670–1678 (2019).
pubmed: 31740837 pmcid: 6885121 doi: 10.1038/s41588-019-0512-x
International Schizophrenia Consortium. Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460, 748–752 (2009).
pmcid: 3912837 doi: 10.1038/nature08185
Chatterjee, N., Shi, J. & García-Closas, M. Developing and evaluating polygenic risk prediction models for stratified disease prevention. Nat. Rev. Genet. 17, 392–406 (2016).
pubmed: 27140283 pmcid: 6021129 doi: 10.1038/nrg.2016.27
Stahl, E. A. et al. Bayesian inference analyses of the polygenic architecture of rheumatoid arthritis. Nat. Genet. 44, 483–489 (2012).
pubmed: 22446960 pmcid: 6560362 doi: 10.1038/ng.2232
Chatterjee, N. et al. Projecting the performance of risk prediction based on polygenic analyses of genome-wide association studies. Nat. Genet. 45, 405e1–405e3 (2013).
doi: 10.1038/ng.2579
Khera, A. V. et al. Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations. Nat. Genet. 50, 1219–1224 (2018).
pubmed: 30104762 pmcid: 6128408 doi: 10.1038/s41588-018-0183-z
Schumacher, F. R. et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat. Genet. 50, 928–936 (2018).
pubmed: 29892016 pmcid: 6568012 doi: 10.1038/s41588-018-0142-8
Sharp, S. A. et al. Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis. Diabetes Care 42, 200–207 (2019).
pubmed: 30655379 pmcid: 6341291 doi: 10.2337/dc18-1785
Kullo, I. J. et al. Incorporating a genetic risk score into coronary heart disease risk estimates: effect on low-density lipoprotein cholesterol levels (the MI-GENES Clinical Trial). Circulation 133, 1181–1188 (2016).
pubmed: 26915630 pmcid: 4803581 doi: 10.1161/CIRCULATIONAHA.115.020109
Natarajan, P. et al. Polygenic risk score identifies subgroup with higher burden of atherosclerosis and greater relative benefit from statin therapy in the primary prevention setting. Circulation 135, 2091–2101 (2017).
pubmed: 28223407 pmcid: 5484076 doi: 10.1161/CIRCULATIONAHA.116.024436
Márquez-Luna, C., Loh, P.-R., South Asian type 2 Diabetes (SAT2D) Consortium, SIGMA Type 2 Diabetes Consortium & Price, A. L. Multiethnic polygenic risk scores improve risk prediction in diverse populations. Genet. Epidemiol. 41, 811–823 (2017).
pubmed: 29110330 pmcid: 5726434 doi: 10.1002/gepi.22083
Duncan, L. et al. Analysis of polygenic risk score usage and performance in diverse human populations. Nat. Commun. 10, 3328 (2019).
pubmed: 31346163 pmcid: 6658471 doi: 10.1038/s41467-019-11112-0
Curtis, D. Polygenic risk score for schizophrenia is more strongly associated with ancestry than with schizophrenia. Psychiatr. Genet. 28, 85–89 (2018).
pubmed: 30160659 doi: 10.1097/YPG.0000000000000206
Martin, A. R. et al. Human demographic history impacts genetic risk prediction across diverse populations. Am. J. Hum. Genet. 100, 635–649 (2017).
pubmed: 28366442 pmcid: 5384097 doi: 10.1016/j.ajhg.2017.03.004
Hu, Y. et al. Leveraging functional annotations in genetic risk prediction for human complex diseases. PLoS Comput. Biol. 13, e1005589 (2017).
pubmed: 28594818 pmcid: 5481142 doi: 10.1371/journal.pcbi.1005589
Márquez-Luna, C. et al. Modeling functional enrichment improves polygenic prediction accuracy in UK Biobank and 23andMe data sets. Preprint at bioRxiv https://doi.org/10.1101/375337 (2018).
Okada, Y. et al. Genetics of rheumatoid arthritis contributes to biology and drug discovery. Nature 506, 376–381 (2014).
pubmed: 24390342 doi: 10.1038/nature12873
Kanai, M. et al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat. Genet. 50, 390–400 (2018).
doi: 10.1038/s41588-018-0047-6 pubmed: 29403010
Yengo, L. et al. Meta-analysis of genome-wide association studies for height and body mass index in ∼700000 individuals of European ancestry. Hum. Mol. Genet. 27, 3641–3649 (2018).
pubmed: 30124842 pmcid: 6488973 doi: 10.1093/hmg/ddy271
Schaub, M. A., Boyle, A. P., Kundaje, A., Batzoglou, S. & Snyder, M. Linking disease associations with regulatory information in the human genome. Genome Res. 22, 1748–1759 (2012).
pubmed: 22955986 pmcid: 3431491 doi: 10.1101/gr.136127.111
Maurano, M. T. et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337, 1190–1195 (2012).
pubmed: 22955828 pmcid: 3771521 doi: 10.1126/science.1222794
Reshef, Y. A. et al. Detecting genome-wide directional effects of transcription factor binding on polygenic disease risk. Nat. Genet. 50, 1483–1493 (2018).
pubmed: 30177862 pmcid: 6202062 doi: 10.1038/s41588-018-0196-7
Liu, X., Li, Y. I. & Pritchard, J. K. Trans effects on gene expression can drive omnigenic inheritance. Cell 177, 1022–1034.e6 (2019).
pubmed: 31051098 pmcid: 6553491 doi: 10.1016/j.cell.2019.04.014
Lloyd-Jones, L. R. et al. Improved polygenic prediction by Bayesian multiple regression on summary statistics. Nat. Commun. 10, 5086 (2019).
pubmed: 31704910 pmcid: 6841727 doi: 10.1038/s41467-019-12653-0
Amariuta, T. et al. IMPACT: genomic annotation of cell-state-specific regulatory elements inferred from the epigenome of bound transcription factors. Am. J. Hum. Genet. 104, 879–895 (2019).
pubmed: 31006511 pmcid: 6506796 doi: 10.1016/j.ajhg.2019.03.012
Kawakami, E., Nakaoka, S., Ohta, T. & Kitano, H. Weighted enrichment method for prediction of transcription regulators from transcriptome and global chromatin immunoprecipitation data. Nucleic Acids Res. 44, 5010–5021 (2016).
pubmed: 27131787 pmcid: 4914117 doi: 10.1093/nar/gkw355
ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012).
doi: 10.1038/nature11247
Roadmap EpigenomicsConsortium. Integrative analysis of 111 reference human epigenomes. Nature 518, 317–330 (2015).
Gazal, S. et al. Linkage disequilibrium–dependent architecture of human complex traits shows action of negative selection. Nat. Genet. 49, 1421–1427 (2017).
pubmed: 28892061 pmcid: 6133304 doi: 10.1038/ng.3954
Buniello, A. et al. The NHGRI-EBI GWAS Catalog of published genome-wide association studies, targeted arrays and summary statistics 2019. Nucleic Acids Res. 47, D1005–D1012 (2019).
pubmed: 30445434 doi: 10.1093/nar/gky1120
Akiyama, M. et al. Characterizing rare and low-frequency height-associated variants in the Japanese population. Nat. Commun. 10, 4393 (2019).
pubmed: 31562340 pmcid: 6764965 doi: 10.1038/s41467-019-12276-5
Akiyama, M. et al. Genome-wide association study identifies 112 new loci for body mass index in the Japanese population. Nat. Genet. 49, 1458–1467 (2017).
pubmed: 28892062 doi: 10.1038/ng.3951
Ishigaki, K. et al. Large-scale genome-wide association study in a Japanese population identifies novel susceptibility loci across different diseases. Nat. Genet. 52, 669–679 (2020).
pubmed: 32514122 doi: 10.1038/s41588-020-0640-3 pmcid: 7968075
Peterson, R. E. et al. Genome-wide association studies in ancestrally diverse populations: opportunities, methods, pitfalls, and recommendations. Cell 179, 589–603 (2019).
pubmed: 31607513 pmcid: 6939869 doi: 10.1016/j.cell.2019.08.051
Gurdasani, D., Barroso, I., Zeggini, E. & Sandhu, M. S. Genomics of disease risk in globally diverse populations. Nat. Rev. Genet. 20, 520–535 (2019).
pubmed: 31235872 doi: 10.1038/s41576-019-0144-0
Drake, L. Y. et al. B cells play key roles in th2-type airway immune responses in mice exposed to natural airborne allergens. PLoS One 10, e0121660 (2015).
pubmed: 25803300 pmcid: 4372217 doi: 10.1371/journal.pone.0121660
Amariuta, T., Luo, Y., Knevel, R., Okada, Y. & Raychaudhuri, S. Advances in genetics toward identifying pathogenic cell states of rheumatoid arthritis. Immunol. Rev. 294, 188–204 (2019).
pubmed: 31782165 doi: 10.1111/imr.12827 pmcid: 7047592
Buttari, B., Profumo, E. & Riganò, R. Crosstalk between red blood cells and the immune system and its impact on atherosclerosis. Biomed. Res. Int. 2015, 616834 (2015).
pubmed: 25722984 pmcid: 4334626 doi: 10.1155/2015/616834
Anderson, H. L., Brodsky, I. E. & Mangalmurti, N. S. The evolving erythrocyte: red blood cells as modulators of innate immunity. J. Immunol. 201, 1343–1351 (2018).
pubmed: 30127064 doi: 10.4049/jimmunol.1800565
Lui, J. C. & Baron, J. Mechanisms limiting body growth in mammals. Endocr. Rev. 32, 422–440 (2011).
pubmed: 21441345 pmcid: 3365796 doi: 10.1210/er.2011-0001
Maier, A. B., van Heemst, D. & Westendorp, R. G. J. Relation between body height and replicative capacity of human fibroblasts in nonagenarians. J. Gerontol. A Biol. Sci. Med. Sci. 63, 43–45 (2008).
pubmed: 18245759 doi: 10.1093/gerona/63.1.43
Murphy, R. A. et al. Adipose tissue, muscle, and function: potential mediators of associations between body weight and mortality in older adults with type 2 diabetes. Diabetes Care 37, 3213–3219 (2014).
pubmed: 25315206 pmcid: 4237983 doi: 10.2337/dc14-0293
Heymsfield, S. B., Gallagher, D., Mayer, L., Beetsch, J. & Pietrobelli, A. Scaling of human body composition to stature: new insights into body mass index. Am. J. Clin. Nutr. 86, 82–91 (2007).
pubmed: 17616766 doi: 10.1093/ajcn/86.1.82
Kichaev, G. et al. Leveraging polygenic functional enrichment to improve GWAS power. Am. J. Hum. Genet. 104, 65–75 (2019).
doi: 10.1016/j.ajhg.2018.11.008 pubmed: 30595370
Gusev, A. et al. Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation. Nat. Commun. 7, 10979 (2016).
pubmed: 27052111 pmcid: 4829663 doi: 10.1038/ncomms10979
Finucane, H. K. et al. Heritability enrichment of specifically expressed genes identifies disease-relevant tissues and cell types. Nat. Genet. 50, 621–629 (2018).
pubmed: 29632380 pmcid: 5896795 doi: 10.1038/s41588-018-0081-4
Gibbs, R. A. et al. A global reference for human genetic variation. Nature 526, 68–74 (2015).
doi: 10.1038/nature15393
Zhou, J. & Troyanskaya, O. G. Predicting effects of noncoding variants with deep learning-based sequence model. Nat. Methods 12, 931–934 (2015).
pubmed: 26301843 pmcid: 4768299 doi: 10.1038/nmeth.3547
Chen, K. M., Cofer, E. M., Zhou, J. & Troyanskaya, O. G. Selene: a PyTorch-based deep learning library for sequence data. Nat. Methods 16, 315–318 (2019).
pubmed: 30923381 pmcid: 7148117 doi: 10.1038/s41592-019-0360-8
Kelley, D. R. et al. Sequential regulatory activity prediction across chromosomes with convolutional neural networks. Genome Res. 28, 739–750 (2018).
pubmed: 29588361 pmcid: 5932613 doi: 10.1101/gr.227819.117
Dey, K. K. et al. Evaluating the informativeness of deep learning annotations for human complex diseases. Nat. Commun. 11, 4703 (2020).
pubmed: 32943643 pmcid: 7499261 doi: 10.1038/s41467-020-18515-4
Nagai, A. et al. Overview of the BioBank Japan Project: study design and profile. J. Epidemiol. 27, S2–S8 (2017).
pubmed: 28189464 pmcid: 5350590 doi: 10.1016/j.je.2016.12.005
Hirata, M. et al. Cross-sectional analysis of BioBank Japan clinical data: a large cohort of 200,000 patients with 47 common diseases. J. Epidemiol. 27, S9–S21 (2017).
pubmed: 28190657 pmcid: 5363792 doi: 10.1016/j.je.2016.12.003
Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576–589 (2010).
pubmed: 20513432 pmcid: 2898526 doi: 10.1016/j.molcel.2010.05.004
Yang, J. et al. Common SNPs explain a large proportion of the heritability for human height. Nat. Genet. 42, 565–569 (2010).
pubmed: 20562875 pmcid: 3232052 doi: 10.1038/ng.608
Yang, J., Zeng, J., Goddard, M. E., Wray, N. R. & Visscher, P. M. Concepts, estimation and interpretation of SNP-based heritability. Nat. Genet. 49, 1304–1310 (2017).
pubmed: 28854176 doi: 10.1038/ng.3941
Purcell, S. et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. Am. J. Hum. Genet. 81, 559–575 (2007).
pubmed: 17701901 pmcid: 1950838 doi: 10.1086/519795
Lee, S. H., Goddard, M. E., Wray, N. R. & Visscher, P. M. A better coefficient of determination for genetic profile analysis. Genet. Epidemiol. 36, 214–224 (2012).
pubmed: 22714935 doi: 10.1002/gepi.21614

Auteurs

Tiffany Amariuta (T)

Center for Data Sciences, Harvard Medical School, Boston, MA, USA.
Divisions of Genetics and Rheumatology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA.
Graduate School of Arts and Sciences, Harvard University, Cambridge, MA, USA.

Kazuyoshi Ishigaki (K)

Center for Data Sciences, Harvard Medical School, Boston, MA, USA.
Divisions of Genetics and Rheumatology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.

Hiroki Sugishita (H)

Laboratory for Developmental Genetics, RIKEN Center for Integrative Medical Sciences (IMS), Kanagawa, Japan.

Tazro Ohta (T)

Medical Sciences Innovation Hub Program, RIKEN, Kanagawa, Japan.
Database Center for Life Science, Joint Support-Center for Data Science Research, Research Organization of Information and Systems, Shizuoka, Japan.

Masaru Koido (M)

Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Kushal K Dey (KK)

Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Koichi Matsuda (K)

Laboratory of Genome Technology, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
Laboratory of Clinical Genome Sequencing, Department of Computational Biology and Medical Sciences, Graduate School of Frontier Sciences, The University of Tokyo, Tokyo, Japan.

Yoshinori Murakami (Y)

Division of Molecular Pathology, Institute of Medical Science, The University of Tokyo, Tokyo, Japan.

Alkes L Price (AL)

Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA, USA.
Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, MA, USA.

Eiryo Kawakami (E)

Medical Sciences Innovation Hub Program, RIKEN, Kanagawa, Japan.
Artificial Intelligence Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan.

Chikashi Terao (C)

Laboratory for Statistical and Translational Genetics, RIKEN Center for Integrative Medical Sciences, Kanagawa, Japan.
Clinical Research Center, Shizuoka General Hospital, Shizuoka, Japan.
Department of Applied Genetics, The School of Pharmaceutical Sciences, University of Shizuoka, Shizuoka, Japan.

Soumya Raychaudhuri (S)

Center for Data Sciences, Harvard Medical School, Boston, MA, USA. soumya@broadinstitute.org.
Divisions of Genetics and Rheumatology, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. soumya@broadinstitute.org.
Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA. soumya@broadinstitute.org.
Department of Biomedical Informatics, Harvard Medical School, Boston, MA, USA. soumya@broadinstitute.org.
Centre for Genetics and Genomics Versus Arthritis, Centre for Musculoskeletal Research, Manchester Academic Health Science Centre, The University of Manchester, Manchester, UK. soumya@broadinstitute.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH